HNGE — Hinge Health, Inc.

Hinge Health Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $213 million, up 53% year-over-year, exceeding guidance of $200-$202 million.
• Last 12 Months (LTM) Calculated Billings: $862 million, a 52% increase from the previous year.
• Operating Income: $62 million, more than double from a year ago, with an operating margin of 29% (up from 19%).
• Free Cash Flow: $100 million, a significant increase from $33 million in Q2 2025, yielding a free cash flow margin of 47%.
• Cash Position: $476 million in cash and equivalents, excluding the upcoming $105 million acquisition of Cylinder Health.

2. Strategic Updates and Business Highlights

• Product Expansion: Hinge Health is transitioning from a focus on musculoskeletal (MSK) care to include migraine and gastrointestinal (GI) health.
  • Migraine Care Program: Launched with over 450 clients covering 5 million lives, showing strong early engagement.
  • Acquisition of Cylinder Health: For $105 million, aimed at enhancing GI offerings, with expectations of $7-$8 million in revenue contribution for the remainder of 2026.
• Market Position: Hinge Health serves nearly 3,000 clients, including over half of the Fortune 100, and emphasizes a multi-product strategy to deepen client relationships.
• Sales Momentum: Strong pipeline growth with notable wins in both enterprise and SMB segments, including a significant deal with a Fortune 15 company.

3. Forward Guidance and Outlook

• Q3 2026 Revenue Guidance: $223-$225 million, representing 45% year-over-year growth.
• Full-Year 2026 Revenue Guidance: Raised to $856-$860 million, a 46% increase compared to 2025.
• Operating Income Guidance: Increased to $236-$244 million, maintaining a 28% operating margin.
• Yield Expectations: Anticipated yield of 4.45% for the year, driven by improvements in member engagement and targeted enrollment strategies.

4. Challenges and Points of Concern

• Integration Risks: The acquisition of Cylinder Health will require integration efforts, which may incur costs and operational challenges.
• Competitive Pressures: Increased competition in the market, with competitors reporting high win rates, necessitating Hinge Health to maintain its competitive edge through product quality and client satisfaction.
• Market Scrutiny: Buyers are demanding more evidence of ROI and effective outcomes, which could lengthen the sales cycle.

5. Notable Q&A Insights

• GI Market Entry: Daniel Perez emphasized the replicability of Hinge Health's model in GI, leveraging existing technology and expertise to automate care delivery.
• Competitive Landscape: Jim Pursley noted that Hinge Health's win rates are at an all-time high, attributing success to product quality and client engagement.
• Integration of Cylinder Health: The leadership team from Cylinder will transition to Hinge, ensuring continuity in client relationships and operational integration.
• Yield Improvement: Yield improvements are broad-based, with both existing and new clients contributing to the increase, indicating strong potential for future growth.

Overall, Hinge Health reported a robust quarter with strong financial performance and strategic advancements, while also acknowledging the challenges posed by competition and integration efforts.